Dual Kv7 channel/TPSO receptor activator GRT-X shows promise in a refractory seizure model Jan. 31, 2022
Discovery of novel ABCB1 inhibitors that can help overcome ABCB1-mediated chemotherapy resistance Dec. 29, 2021
RSS